Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

BackgroundPeripheral artery disease (PAD) affects millions globally, causing significant morbidity. Traditional treatments like plain old balloon angioplasty (POBA) have limited success due to high restenosis rates.

Angioplasty 52

Angioplasty Peripheral Arterial Disease Outcomes Research 52

DAIC

APRIL 11, 2024

The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. of patients who received IVUS and 70.1%

Peripheral Arterial Disease 116

Peripheral Arterial Disease Ultrasound Angioplasty Plaque 116

AMS Cardiology

NOVEMBER 4, 2023

However, when these arteries become narrowed or blocked conditions like Peripheral Artery Disease (PAD) can emerge, posing a threat to our overall health. Understanding Peripheral Artery Disease Peripheral artery disease or PAD is a condition in which plaque builds up in the arteries that lead to the legs and feet.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Blood Pressure Diet Exercise 52

HCPLive

APRIL 29, 2024

Abbott's Esprit BTK System was shown to significantly reduce risk of ischemic events in patients with PAD versus angioplasty over 1 year.

Peripheral Arterial Disease 111

Peripheral Arterial Disease Angioplasty Stent Stents 111

DAIC

JANUARY 18, 2024

(Photo: Business Wire milla1cf Thu, 01/18/2024 - 14:05 January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for patients with below-knee peripheral arterial disease (PAD) were performed successfully using its Finesse Injectable balloon catheter platform.

Angioplasty 105

Angioplasty Peripheral Arterial Disease Kidney Disease Laboratory 105

Circulation

NOVEMBER 11, 2024

Inclusion criteria included adults over 20 years old, consent to participate, and a requirement for angioplasty. Blood samples were processed to isolate leukocytes, and DNA was extracted using the DNeasy blood kit. Bisulfite pyrosequencing was performed to quantify CpG site-specific DNA methylation at the VTRNA2-1 promoter locus.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Biomarkers Angioplasty Atherosclerosis 40

Med Page Today

APRIL 30, 2024

(MedPage Today) -- For patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia, drug-eluting stents and drug-coated balloons did not improve amputation-free survival compared with balloon angioplasty alone in the BASIL.

Peripheral Arterial Disease 64

Peripheral Arterial Disease Angioplasty Heart Disease Cancer 64